(Q53278296)

12 May 2018

title

¹⁸F-FDG PET and biomarkers for tumour angiogenesis in early breast cancer. (English)

1 reference

12 May 2018

1 reference

1 reference

Manuel Rodriguez-Justo

3

1 reference

12 May 2018

author name string

Ashley M Groves

1

1 reference

12 May 2018

Manu Shastry

2

1 reference

12 May 2018

Anmol Malhotra

4

1 reference

12 May 2018

Raymondo Endozo

5

1 reference

12 May 2018

Timothy Davidson

6

1 reference

12 May 2018

Tina Kelleher

7

1 reference

12 May 2018

Kenneth A Miles

8

1 reference

12 May 2018

Peter J Ell

9

1 reference

12 May 2018

Mohammed R Keshtgar

10

1 reference

12 May 2018

publication date

14 August 2010

1 reference

12 May 2018

number of pages

7

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

12 May 2018

volume

38

1 reference

12 May 2018

issue

1

1 reference

12 May 2018

page(s)

46-52

1 reference

12 May 2018

https://scigraph.springernature.com/pub.10.1007/s00259-010-1590-2

exact match

0 references

cites work

Standardized perfusion value: universal CT contrast enhancement scale that correlates with FDG PET in lung nodules

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00259-010-1590-2

Targeting cancer vasculature via endoglin/CD105: a novel antibody-based diagnostic and therapeutic strategy in solid tumours

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00259-010-1590-2

Correlation of angiogenesis with 18F-FMT and 18F-FDG uptake in non-small cell lung cancer

21 January 2018

1 reference

12 December 2020

Prediction of metastasis risk (11 year follow-up) using VEGF-R1, VEGF-R2, Tie-2/Tek and CD105 expression in breast cancer (n=905).

1 reference

12 December 2020

Vascular endothelial growth factor and endoglin expression in colorectal cancer

1 reference

12 December 2020

Microvessel density: correlation with 18F-FDG uptake and prognostic impact in lung adenocarcinomas

1 reference

12 December 2020

Bevacizumab and breast cancer: current therapeutic progress and future perspectives

1 reference

12 December 2020

Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human p

1 reference

12 December 2020

Response to therapy in breast cancer

1 reference

12 December 2020

Endoglin (CD105) expression in angiogenesis of primary hepatocellular carcinomas: analysis using tissue microarrays and comparisons with CD34 and VEGF

1 reference

12 December 2020

The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations.

1 reference

12 December 2020

CD 105 and angiogenesis

1 reference

12 December 2020

Expression of the vascular endothelial growth factor receptor-2/Flk-1 in breast carcinomas: correlation with proliferation

1 reference

12 December 2020

Imaging of angiogenesis: from microscope to clinic

1 reference

12 December 2020

18F-FDG PET of locally invasive breast cancer and association of estrogen receptor status with standardized uptake value: microarray and immunohistochemical analysis

1 reference

12 December 2020

Evaluation of angiogenesis in non-small cell lung cancer: comparison between anti-CD34 antibody and anti-CD105 antibody

1 reference

12 December 2020

Metabolic-flow relationships in primary breast cancer: feasibility of combined PET/dynamic contrast-enhanced CT.

1 reference

12 December 2020

Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world

1 reference

12 December 2020

Effect of (18)F-FDG PET/CT imaging in patients with clinical Stage II and III breast cancer

1 reference

12 December 2020

Non-[18F]FDG PET in clinical oncology

1 reference

12 December 2020

Phase I trial of the positron-emitting Arg-Gly-Asp (RGD) peptide radioligand 18F-AH111585 in breast cancer patients

1 reference

12 December 2020

Changes in blood flow and metabolism in locally advanced breast cancer treated with neoadjuvant chemotherapy

1 reference

12 December 2020

Recent advances in systemic therapy: new diagnostics and biological predictors of outcome in early breast cancer.

1 reference

12 December 2020

Uptake of 18F-Fluorocholine, 18F-FET, and 18F-FDG in C6 gliomas and correlation with 131I-SIP(L19), a marker of angiogenesis.

1 reference

12 December 2020

Lack of correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in non-small cell lung cancer assessed by 18F-Fluoromisonidazole and 18F-FDG PET.

1 reference

12 December 2020

Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma

1 reference

12 December 2020

Prognostic significance of angiogenesis evaluated by CD105 expression compared to CD31 in 905 breast carcinomas: correlation with long-term patient outcome

1 reference

12 December 2020

Hypoxia inducible factor-alpha expression correlates with vascular endothelial growth factor-C expression and lymphangiogenesis/angiogenesis in oral squamous cell carcinoma

1 reference

12 December 2020

Expression of endoglin (CD105) in cervical cancer

1 reference

12 December 2020

Long-term prognostic significance of neoangiogenesis in breast carcinomas: comparison of Tie-2/Tek, CD105, and CD31 immunocytochemical expression

1 reference

12 December 2020

Biologic correlates of (18)fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography

1 reference

12 December 2020

Blood flow-metabolic relationships are dependent on tumour size in non-small cell lung cancer: a study using quantitative contrast-enhanced computer tomography and positron emission tomography

1 reference

12 December 2020

Functional CT imaging in oncology.

1 reference

12 December 2020

Impact of angiogenesis-related gene expression on the tracer kinetics of 18F-FDG in colorectal tumors

1 reference

12 December 2020

Morphology of angiogenesis in human cancer: a conceptual overview, histoprognostic perspective and significance of neoangiogenesis

1 reference

12 December 2020

Preoperative staging of large primary breast cancer with [18F]fluorodeoxyglucose positron emission tomography/computed tomography compared with conventional imaging procedures

1 reference

12 December 2020

Hypoxia, hypoxia-inducible transcription factor, and macrophages in human atherosclerotic plaques are correlated with intraplaque angiogenesis

1 reference

12 December 2020

18F-FDG uptake in lung, breast, and colon cancers: molecular biology correlates and disease characterization

1 reference

12 December 2020

HIF-1 and tumor progression: pathophysiology and therapeutics

1 reference

12 December 2020

Breast carcinoma: vascular density determined using CD105 antibody correlates with tumor prognosis

1 reference

12 December 2020

Recommendations on the use of 18F-FDG PET in oncology

1 reference

12 December 2020

Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET).

1 reference

12 December 2020

Microvessel density as a prognostic factor in women with breast cancer: a systematic review of the literature and meta-analysis

1 reference

12 December 2020

10.1007/S00259-010-1590-2

Identifiers

DOI

1 reference

12 May 2018

1 reference

12 May 2018